SCHEMBL29625292

SCHEMBL29625292

CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 6/20 0.50
▸ TFPI P10646 1/20 0.50
▸ VIPR1 P32241 1/20 0.46
▸ NR3C1 P04150 1/20 0.45
▸ RAMP3 O60896 3/20 0.45
▸ CALCR P30988 3/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625291 0.98 OPRL1 (0.50) OPRL1TFPIVIPR1RAMP3CALCR
Parasin I SCHEMBL29412266 0.89 OPRL1 (0.52) OPRL1TFPINR3C1
SCHEMBL29736280 0.89 IL23R (0.46) OPRL1TFPIRXFP1
SCHEMBL16055575 0.89 RXFP1 (0.48) OPRL1TFPIRAMP3CALCRRXFP1
SCHEMBL29625293 0.88 OPRL1 (0.45) OPRL1TFPI
SCHEMBL30431362 0.88 OPRL1 (0.54) OPRL1TFPIVIPR1NR3C1RAMP3
SCHEMBL30437367 0.87 TFPI (0.56) OPRL1TFPIVIPR1RAMP3CALCR
SCHEMBL30595713 0.86 TFPI (0.48) TFPI
SCHEMBL29808495 0.86 NPY4R (0.51) TFPI
SCHEMBL30432774 0.86 OPRL1 (0.53) OPRL1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112759635-B Bioactive peptide with amino acid structure VAKVTGGAASKL, and preparation method and application thereof 浙江辉肽生命健康科技有限公司 2022-05-31 — — CN claimed
CN-112759635-B Bioactive peptide with amino acid structure VAKVTGGAASKL, and preparation method and application thereof 浙江辉肽生命健康科技有限公司 2022-05-31 — — CN disclosed
Send feedback